Robust Intrapulmonary CD8 T Cell Responses and Protection with an Attenuated N1L Deleted Vaccinia Virus

Anuja Mathew, Joel O'Bryan, William Marshall et al. · 2008

Read Robust Intrapulmonary CD8 T Cell Responses and Protection with an Attenuated N1L Deleted Vaccinia Virus by Anuja Mathew, Joel O'Bryan, William Marshall et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003323.txt.

Description

Anuja Mathew, Joel O'Bryan, William Marshall and colleagues test a weakened vaccinia vaccine in this 2008 PLOS ONE paper. Vaccinia viruses have been used as a model for viral disease and as a protective live vaccine. The team investigated the immunogenicity of an attenuated strain of vaccinia virus engineered to inactivate the N1L gene, called vGK5. Using the intranasal route, this recombinant virus was far less virulent.

The title reports robust intrapulmonary CD8 T cell responses and protection with the N1L deleted virus. Readers see safety improved while lung T cell protection stayed strong. That trade-off is the central problem of live vaccine design.

Catalog record

CREATORAnuja Mathew, Joel O'Bryan, William Marshall et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003323

Browse the full library · About the Tower of Babel